Trilogy Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.89M Buy
45,029
+3,707
+9% +$327K 0.15% 114
2026
Q2
$3.23M Buy
41,322
+2,843
+7% +$229K 0.13% 133
2026
Q1
$3.33M Buy
38,479
+748
+2% +$71.7K 0.15% 112
2025
Q4
$3.62M Buy
37,731
+30,679
+435% +$2.98M 0.16% 102
2025
Q3
$672K Buy
7,052
+70
+1% +$6.44K 0.03% 214
2025
Q2
$609K Buy
6,982
+202
+3% +$17.1K 0.03% 215
2025
Q1
$609K Sell
6,780
-42
-0.6% -$3.76K 0.03% 207
2024
Q4
$545K Buy
6,822
+2,740
+67% +$237K 0.03% 219
2024
Q3
$368K Buy
4,082
+192
+5% +$16.2K 0.02% 259
2024
Q2
$306K Buy
3,890
+1,395
+56% +$114K 0.02% 267
2024
Q1
$217K Sell
2,495
-225
-8% -$19.2K 0.01% 282
2023
Q4
$224K Buy
+2,720
New +$207K 0.01% 252
2023
Q3
– Sell
-2,341
Closed -$208K – 268
2023
Q2
$208K Buy
+2,341
New +$202K 0.01% 264
2018
Q4
– Sell
-177
Closed -$17K – 395
2018
Q3
$17K Buy
177
+39
+28% +$3.61K ﹤0.01% 283
2018
Q2
$12K Buy
138
+55
+66% +$4.59K ﹤0.01% 283
2018
Q1
$7K Buy
+83
New +$6.85K ﹤0.01% 289

Other funds holding MDT

Trilogy Capital's MDT Position: Q3 2026 in Review

Trilogy Capital increased its Medtronic (MDT) stake by 9% in Q3 2026, buying an estimated $327K and bringing the position to 45,029 shares worth $3.89M. The position accounts for 0.15% of the portfolio, ranked #114.

Trilogy Capital first reported a position in MDT in Q1 2018 and has held it in 16 quarters since. 644 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Trilogy Capital held 45,029 shares of Medtronic worth $3.89M as of Q3 2026.
  • Trilogy Capital bought 3,707 Medtronic shares in Q3 2026, an estimated $327K.
  • Medtronic made up 0.15% of Trilogy Capital's portfolio in Q3 2026, its #114 holding.
  • Trilogy Capital first reported a position in Medtronic in Q1 2018 and has held it in 16 quarters since.
  • 644 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Trilogy Capital's 13F filing for Q3 2026, filed 20 Oct 2026.